Author Correction: Fatty acid metabolism constrains Th9 cell differentiation and antitumor immunity via the modulation of retinoic acid receptor signaling.

Autor: Nakajima T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan., Kanno T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan., Ueda Y; Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Miyako K; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan.; Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan., Endo T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan., Yoshida S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan., Yokoyama S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan., Asou HK; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan., Yamada K; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan., Ikeda K; Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan., Togashi Y; Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.; Division of Cell Therapy, Chiba Cancer Center Research Institute, 666-2 Nitona-cho, Chuo-ku, Chiba, 260-8717, Japan., Endo Y; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba, 292-0818, Japan. endo@kazusa.or.jp.; Department of Omics Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan. endo@kazusa.or.jp.

Publikováno v: Cellular & molecular immunology [Cell Mol Immunol] 2024 Nov; Vol. 21 (11), pp. 1350.

The integration of metabolic and proteomic data uncovers an augmentation of the sphingolipid biosynthesis pathway during T-cell differentiation.

Autor: Kanno T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Konno R; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Sato M; Department of Research and Development, Kazusa DNA Research Institutes, Kisarazu, Japan., Kurabayashi A; Department of Research and Development, Kazusa DNA Research Institutes, Kisarazu, Japan., Miyako K; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Nakajima T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Yokoyama S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Sasamoto S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Asou HK; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Ohzeki J; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Hasegawa Y; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Ikeda K; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Kawashima Y; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Ohara O; Department of Applied Genomics Kazusa DNA Research Institute, Kisarazu, Chiba, Japan., Endo Y; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Chiba, Japan. endo@kazusa.or.jp.; Department of Omics Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan. endo@kazusa.or.jp.

Publikováno v: Communications biology [Commun Biol] 2024 May 23; Vol. 7 (1), pp. 622. Date of Electronic Publication: 2024 May 23.

1-Oleoyl-lysophosphatidylethanolamine stimulates RORγt activity in T H 17 cells.

Autor: Endo Y; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan.; Department of Omics Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana. Chuo-ku, Chiba 260-8670 Japan.; AMED-CREST, AMED, Tokyo, Japan., Kanno T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Nakajima T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Ikeda K; Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Taketomi Y; Laboratory of Microenvironmental Metabolic Health Sciences Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 Japan., Yokoyama S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Sasamoto S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Asou HK; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Miyako K; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan.; Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Hasegawa Y; Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Kawashima Y; Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Ohara O; Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Murakami M; AMED-CREST, AMED, Tokyo, Japan.; Laboratory of Microenvironmental Metabolic Health Sciences Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 Japan., Nakayama T; AMED-CREST, AMED, Tokyo, Japan.; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana. Chuo-ku, Chiba 260-8670 Japan.

Publikováno v: Science immunology [Sci Immunol] 2023 Aug 04; Vol. 8 (86), pp. eadd4346. Date of Electronic Publication: 2023 Aug 04.

SCD2-mediated cooperative activation of IRF3-IRF9 regulatory circuit controls type I interferon transcriptome in CD4 ⁺ T cells.

Autor: Kanno T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Chiba, Japan., Miyako K; Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan., Nakajima T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Chiba, Japan., Yokoyama S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Chiba, Japan., Sasamoto S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Chiba, Japan., Asou HK; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Chiba, Japan., Ohara O; Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan., Nakayama T; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.; Japan Agency for Medical Research and Development (AMED) - Core Research for Evolutional Science and Technology (CREST), AMED, Chiba, Japan., Endo Y; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Chiba, Japan.; Department of Omics Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Aug 18; Vol. 13, pp. 904875. Date of Electronic Publication: 2022 Aug 18 (Print Publication: 2022).

Acsbg1-dependent mitochondrial fitness is a metabolic checkpoint for tissue T reg cell homeostasis.

Autor: Kanno T; Laboratory of Medical Omics Research, Department of Frontier Research and Development, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan., Nakajima T; Laboratory of Medical Omics Research, Department of Frontier Research and Development, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan., Kawashima Y; Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan., Yokoyama S; Laboratory of Medical Omics Research, Department of Frontier Research and Development, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan., Asou HK; Laboratory of Medical Omics Research, Department of Frontier Research and Development, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan., Sasamoto S; Laboratory of Medical Omics Research, Department of Frontier Research and Development, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan., Hayashizaki K; Department of Bacteriology, The Jikei University School of Medicine, Tokyo, Japan; Jikei Center for Biofilm Science and Technology, The Jikei University School of Medicine, Tokyo, Japan., Kinjo Y; Department of Bacteriology, The Jikei University School of Medicine, Tokyo, Japan; Jikei Center for Biofilm Science and Technology, The Jikei University School of Medicine, Tokyo, Japan., Ohara O; Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan., Nakayama T; Department of Immunology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan; AMED-CREST, AMED, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan., Endo Y; Laboratory of Medical Omics Research, Department of Frontier Research and Development, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan; Department of Omics Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan. Electronic address: endo@kazusa.or.jp.

Publikováno v: Cell reports [Cell Rep] 2021 Nov 09; Vol. 37 (6), pp. 109921.